Loading...

We've got a brand new version of Simply Wall St! Try it out

Tree of Knowledge International

CNSX:TOKI
Snowflake Description

Imperfect balance sheet and overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
TOKI
CNSX
CA$12M
Market Cap
  1. Home
  2. CA
  3. Pharmaceuticals & Biotech
Company description

Tree of Knowledge International Corp. produces and sells hemp-based cannabidiol (CBD) products, including industrial hemp-derived CBD oil, tinctures, capsules, and vape pens. The last earnings update was 24 days ago. More info.


Add to Portfolio Compare Print
  • Tree of Knowledge International has significant price volatility in the past 3 months.
TOKI Share Price and Events
7 Day Returns
0%
CNSX:TOKI
-5.9%
CA Pharmaceuticals
1.3%
CA Market
1 Year Returns
-90.8%
CNSX:TOKI
-46.7%
CA Pharmaceuticals
-0.1%
CA Market
TOKI Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Tree of Knowledge International (TOKI) 0% 10% -54.2% -90.8% - -
CA Pharmaceuticals -5.9% -3.4% -24.8% -46.7% 217.3% 286.4%
CA Market 1.3% 4.2% 1.6% -0.1% 8.4% 5.7%
1 Year Return vs Industry and Market
  • TOKI underperformed the Pharmaceuticals industry which returned -46.7% over the past year.
  • TOKI underperformed the Market in Canada which returned -0.1% over the past year.
Price Volatility
Industry
5yr Volatility vs Market

Value

 Is Tree of Knowledge International undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Tree of Knowledge International. This is due to cash flow or dividend data being unavailable. The share price is CA$0.055.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Tree of Knowledge International's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Tree of Knowledge International's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:TOKI PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-06-30) in USD $-0.07
CNSX:TOKI Share Price ** CNSX (2019-09-19) in CAD CA$0.06
CNSX:TOKI Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.754 $0.04
Canada Pharmaceuticals Industry PE Ratio Median Figure of 13 Publicly-Listed Pharmaceuticals Companies 15.3x
Canada Market PE Ratio Median Figure of 539 Publicly-Listed Companies 14.14x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Tree of Knowledge International.

CNSX:TOKI PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:TOKI Share Price ÷ EPS (both in USD)

= 0.04 ÷ -0.07

-0.6x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Tree of Knowledge International is loss making, we can't compare its value to the CA Pharmaceuticals industry average.
  • Tree of Knowledge International is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does Tree of Knowledge International's expected growth come at a high price?
Raw Data
CNSX:TOKI PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -0.6x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Canada Pharmaceuticals Industry PEG Ratio Median Figure of 7 Publicly-Listed Pharmaceuticals Companies 1.56x
Canada Market PEG Ratio Median Figure of 245 Publicly-Listed Companies 1.02x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Tree of Knowledge International, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Tree of Knowledge International's assets?
Raw Data
CNSX:TOKI PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-06-30) in USD $0.08
CNSX:TOKI Share Price * CNSX (2019-09-19) in CAD CA$0.06
CNSX:TOKI Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.754 $0.04
Canada Pharmaceuticals Industry PB Ratio Median Figure of 151 Publicly-Listed Pharmaceuticals Companies 2.36x
Canada Market PB Ratio Median Figure of 2,457 Publicly-Listed Companies 1.43x
CNSX:TOKI PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:TOKI Share Price ÷ Book Value per Share (both in USD)

= 0.04 ÷ 0.08

0.49x

* Primary Listing of Tree of Knowledge International.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Tree of Knowledge International is good value based on assets compared to the CA Pharmaceuticals industry average.
X
Value checks
We assess Tree of Knowledge International's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. Tree of Knowledge International has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Tree of Knowledge International expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Tree of Knowledge International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
97.7%
Expected Pharmaceuticals industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Tree of Knowledge International expected to grow at an attractive rate?
  • Unable to compare Tree of Knowledge International's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Tree of Knowledge International's earnings growth to the Canada market average as no estimate data is available.
  • Unable to compare Tree of Knowledge International's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
CNSX:TOKI Future Growth Rates Data Sources
Data Point Source Value (per year)
Canada Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 97.7%
Canada Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 56.5%
Canada Market Earnings Growth Rate Market Cap Weighted Average 12.6%
Canada Market Revenue Growth Rate Market Cap Weighted Average 5.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:TOKI Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:TOKI Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-06-30 2 -3 -10
2019-03-31 1 -2 -17
2018-12-31 1 -2 -16
2018-09-30 1 -1 -10
2018-06-30 1 -2 -10
2018-03-31 0 -1 -4
2017-12-31 0 -1 -6
2016-12-31 0 -1 -1

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Tree of Knowledge International is high growth as no earnings estimate data is available.
  • Unable to determine if Tree of Knowledge International is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:TOKI Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Tree of Knowledge International Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:TOKI Past Financials Data
Date (Data in USD Millions) EPS *
2019-06-30 -0.07
2019-03-31 -0.21
2018-12-31 -0.22
2018-09-30 -0.15
2018-06-30 -0.20
2018-03-31 -0.14
2017-12-31 -0.19
2016-12-31 -0.10

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Tree of Knowledge International will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Tree of Knowledge International's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Pharmaceuticals & Biotech companies here
  2. Tree of Knowledge International's competitive advantages and company strategy can generally be found in its financial reports archived here.
  3. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Tree of Knowledge International's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Tree of Knowledge International has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Tree of Knowledge International performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Tree of Knowledge International's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Tree of Knowledge International does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.
  • Unable to compare Tree of Knowledge International's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Tree of Knowledge International's 1-year growth to the CA Pharmaceuticals industry average as it is not currently profitable.
Earnings and Revenue History
Tree of Knowledge International's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Tree of Knowledge International Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:TOKI Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-06-30 1.70 -10.31 5.84 0.00
2019-03-31 1.33 -16.97 9.05 0.03
2018-12-31 0.73 -15.70 7.52 0.07
2018-09-30 0.78 -9.99 6.19 0.07
2018-06-30 0.69 -10.03 6.37 0.07
2018-03-31 0.43 -3.91 3.65 0.04
2017-12-31 0.39 -5.86 5.69
2016-12-31 0.48 -1.23 1.14

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Tree of Knowledge International has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Tree of Knowledge International has efficiently used its assets last year compared to the CA Pharmaceuticals industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Tree of Knowledge International improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Tree of Knowledge International's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Tree of Knowledge International has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Tree of Knowledge International's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Tree of Knowledge International's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Tree of Knowledge International's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Tree of Knowledge International's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Tree of Knowledge International's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 2.7x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Tree of Knowledge International Company Filings, last reported 2 months ago.

CNSX:TOKI Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-06-30 18.06 0.64 0.52
2019-03-31 17.27 0.57 0.54
2018-12-31 18.16 0.57 1.47
2018-09-30 2.39 0.46 0.11
2018-06-30 3.11 0.45 0.11
2018-03-31 -0.28 0.87 0.03
2017-12-31 -0.30 0.02 0.02
2016-12-31 -1.43 1.28 0.01
  • Tree of Knowledge International's level of debt (3.6%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if Tree of Knowledge International's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Tree of Knowledge International has less than a year of cash runway based on current free cash flow.
  • Tree of Knowledge International has less than a year of cash runway if free cash flow continues to grow at historical rates of 41.3% each year.
X
Financial health checks
We assess Tree of Knowledge International's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Tree of Knowledge International has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Tree of Knowledge International's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Tree of Knowledge International dividends.
If you bought CA$2,000 of Tree of Knowledge International shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Tree of Knowledge International's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Tree of Knowledge International's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:TOKI Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
North America Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 2.8%
Canada Market Average Dividend Yield Market Cap Weighted Average of 334 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.1%
Canada Bottom 25% Dividend Yield 25th Percentile 2%
Canada Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Tree of Knowledge International has not reported any payouts.
  • Unable to verify if Tree of Knowledge International's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Tree of Knowledge International's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Tree of Knowledge International has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Tree of Knowledge International's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Tree of Knowledge International afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Tree of Knowledge International has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Tree of Knowledge International's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Michael Caridi
TENURE AS CEO 0.2 years
CEO Bio

Mr. Michael Caridi has been the Chairman of the Board at Tree of Knowledge International Corp. since April 2019, Interim CEO since July 15, 2019 and serves as its Director of Business Development. Mr. Caridi served as the Interim Chief Financial Officer and Director of Tree of Knowledge International Corp. since December 21, 2018. He served as Vice Chairman at Tree of Knowledge International Corp. until April 2019 and previously served as Chairman at Tree of Knowledge, Inc. until December 21, 2018 and served as its Chief Executive Officer until July 2018.

CEO Compensation
  • Insufficient data for Michael to compare compensation growth.
  • Insufficient data for Michael to establish whether their remuneration is reasonable compared to companies of similar size in Canada.
Management Team Tenure

Average tenure of the Tree of Knowledge International management team in years:

0.5
Average Tenure
  • The average tenure for the Tree of Knowledge International management team is less than 2 years, this suggests a new team.
Management Team

Michael Caridi

TITLE
Chairman
TENURE
0.2 yrs

Spence Walker

TITLE
Chief Financial Officer
AGE
61
TENURE
0.3 yrs

Ebby Farzandeh

TITLE
Chief Technology Officer

Scott Reeves

TITLE
Legal Counsel & Director
AGE
49

Cliff Henley

TITLE
COO of South America and VP of Operations - USA & South America

Kevin Rod

TITLE
Chief Medical Advisor & Member of Scientific Board
TENURE
0.8 yrs

Peter Saunders

TITLE
Director of International Business Affairs & Director
TENURE
0.8 yrs

Gary Prihar

TITLE
President of Clinical Operations & Director

Daniel Caridi

TITLE
Assistant to Chairman
Board of Directors Tenure

Average tenure of the Tree of Knowledge International board of directors in years:

1.2
Average Tenure
  • The average tenure for the Tree of Knowledge International board of directors is less than 3 years, this suggests a new board.
Board of Directors

Michael Caridi

TITLE
Chairman
TENURE
0.4 yrs

Scott Reeves

TITLE
Legal Counsel & Director
AGE
49

Kevin Rod

TITLE
Chief Medical Advisor & Member of Scientific Board

Peter Saunders

TITLE
Director of International Business Affairs & Director
TENURE
0.8 yrs

Gary Prihar

TITLE
President of Clinical Operations & Director
TENURE
0.4 yrs

Michael Smatt

TITLE
Member of Scientific Advisory Board
TENURE
1.2 yrs

Jack Brewer

TITLE
Member of Advisory Board
AGE
40
TENURE
1.2 yrs

Rino Adamo

TITLE
Member of Advisory Board

Chris Kaplan

TITLE
Member of Scientific Advisory Board
TENURE
1.2 yrs

Joy Beckerman

TITLE
Member of Advisory Board
TENURE
1.2 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by Tree of Knowledge International individual insiders in the past 3 months, but not in substantial volumes.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
11. Sep 19 Buy Michael Caridi Individual 10. Sep 19 10. Sep 19 44,000 CA$0.04 CA$1,760
09. Sep 19 Buy Michael Caridi Individual 09. Sep 19 09. Sep 19 100,000 CA$0.05 CA$4,500
14. Aug 19 Buy Michael Caridi Individual 13. Aug 19 13. Aug 19 99,000 CA$0.06 CA$6,435
X
Management checks
We assess Tree of Knowledge International's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Tree of Knowledge International has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Some Tree of Knowledge International (CNSX:TOKI) Shareholders Have Taken A Painful 92% Share Price Drop

See our latest analysis for Tree of Knowledge International Because Tree of Knowledge International is loss-making, we think the market is probably more focussed on revenue and revenue growth, at least for now. … In the last year Tree of Knowledge International saw its revenue grow by 211%. … We'd recommend taking a very close look at the stock (and any available forecasts), before considering a purchase, because the share price is not correlated with the revenue growth, that's for sure.

Simply Wall St -

What You Must Know About Tree of Knowledge International Corp's (CNSX:TOKI) Major Investors

In this article, I'm going to take a look at Tree of Knowledge International Corp’s (CNSX:TOKI) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject among investors. … Ownership structure of a company has been found to affect share performance over time. … View our latest analysis for Tree of Knowledge International

Simply Wall St -

Company Info

Description

Tree of Knowledge International Corp. produces and sells hemp-based cannabidiol (CBD) products, including industrial hemp-derived CBD oil, tinctures, capsules, and vape pens. It offers EVR premium hemp oil for the treatment of various ailments, as well as for general wellness purposes. The company also operates multidisciplinary specialty pain clinics, which focuses on the treatment of chronic pain, including controlled applications of medical cannabis; and develops formulated products for therapeutic purposes and natural health product alternatives. Tree of Knowledge International Corp. has a sponsored research agreement with Ryerson University, Toronto for conducting additional research on the ultrasound technology combined with Nano technology delivery methods for the enhancement of medical cannabis and CBD derived therapeutics. It also has a research partnership project with the Ryerson University to develop a Nano-technology-enhanced delivery method for medical cannabis and cannabinoid molecules. The company has operations in the United States, Canada, Europe, Brazil, and China. Tree of Knowledge International Corp. is headquartered in Scarborough, Canada.

Details
Name: Tree of Knowledge International Corp.
TOKI
Exchange: CNSX
Founded:
CA$12,110,910
220,198,372
Website: http://www.tok.ca
Address: Tree of Knowledge International Corp.
633 Coronation Drive,
Scarborough,
Ontario, M1E 2K4,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX TOKI Common Shares Canadian National Stock Exchange CA CAD 03. Jul 2018
OTCPK TOKI.F Common Shares Pink Sheets LLC US USD 03. Jul 2018
DB 0RV Common Shares Deutsche Boerse AG DE EUR 03. Jul 2018
Number of employees
Current staff
Staff numbers
9
Tree of Knowledge International employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/09/22 00:43
End of day share price update: 2019/09/19 00:00
Last earnings filing: 2019/08/29
Last earnings reported: 2019/06/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.